S. 2529 119th Congress Senate

A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

Introduced: July 30, 2025 Introduced by: Jon Husted Republican · Ohio See on congress.gov

Health

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jul 30, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jul 30, 2025

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now July 30, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Related & companion bills 1

Bill text 1 version

Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Health, Education, Labor, and Pensions Committee
Senate

Lobbying activity 13

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

HALEON US HOLDINGS LLC
for HALEON US HOLDINGS LLC · New Jersey · 3rd Quarter 2026 (July 1 - Sep 30)
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
HALEON US HOLDINGS LLC
for HALEON US HOLDINGS LLC · New Jersey · 2nd Quarter 2026 (Apr 1 - June 30)
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
HALEON US HOLDINGS LLC
for HALEON US HOLDINGS LLC · New Jersey · 1st Quarter 2026 (Jan 1 - Mar 31)
AKIN GUMP STRAUSS HAUER & FELD
for CHATTEM, INC. DBA OPELLA · New Jersey · 1st Quarter 2026 (Jan 1 - Mar 31)

Bodies those filers lobbied

HOUSE OF REPRESENTATIVES
13 filings
SENATE
13 filings
Food & Drug Administration (FDA)
8 filings
Health & Human Services, Dept of (HHS)
8 filings
Drug Enforcement Administration (DEA)
5 filings
White House Office
5 filings
Centers For Medicare and Medicaid Services (CMS)
3 filings
Commerce, Dept of (DOC)
3 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 13 filings →

Cosponsors 1

Hassan, Margaret Wood

New Hampshire · Jul 30, 2025

Cite this page click to expand

APA

U.S. Congress. (2026). S. 2529: A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.. 119th Congress. Open America. https://openamerica.io/bill/119-S-2529/

MLA

"S. 2529: A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-2529/.

Bluebook (legal)

S. 2529, 119th Cong. (2026), https://openamerica.io/bill/119-S-2529/.

Markdown link

[S. 2529: A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.](https://openamerica.io/bill/119-S-2529/)